EARKART LIMITED (EARKART) share price
₹130.00 on BSE as of 2026-10-07. +0.00% on the day. market cap ₹178 Cr. P/E 33.7. 52-week range ₹112.00 to ₹256.50. Healthcare.
Earkart FY26: Sales Up 25% to ₹54 Cr, Net Profit of ₹4.93 Cr, and 82 Clinics That Listen Remotely
At a glance
Earkart makes hearing aids in Noida and sells them to the government, to dealers and through small clinics. The money arrives whenever somebody says 'Pardon?'. That makes its customers the only buyers in finance who want the volume turned up.
This article covers FY26, the twelve months to March 2026, and the second half of that year. The second half runs from October 2025 to March 2026. All figures are in ₹crore unless stated otherwise.
Full-year sales were ₹54.04 crore, against ₹43.11 crore the year before. Net profit is what remains once every cost and tax has been paid. It came to ₹4.93 crore in FY26, and ₹6.88 crore a year earlier.
In the six months to March 2026, sales were ₹31.75 crore. Net profit over those six months was ₹3.08 crore. The company holds no loans at the end of the year. The stock market values the whole company at ₹178.8 crore.
The product range is hearing aids under four brands, with accessories and therapy kits beside them. Government buyers accounted for 61.32% of sales in FY26.
The calendar for the year was unusually full. Earkart listed its shares on the stock exchange in October 2025. It won two government orders and announced plans for two acquisitions. It also opened two new subsidiary companies. The company has 58 permanent employees.
Introduction
Earkart began in 2021 and received its BIS licence the same year. BIS is the Bureau of Indian Standards, which certifies that products meet national safety rules. Its first government order followed, for 10,000 hearing aids.
The founder, Managing Director and chief executive is Rohit Misra. He has about 20 years in healthcare, at companies including Glaxo and Starkey. He spent 18 of those years as Starkey's head for South Asia and Africa. He also led a team that set a Guinness World Record for fitting hearing aids. The record was for the most hearing-impaired people fitted in a single day. A world record in hearing aids is an unusual line on a CV.
Management says about 10 crore people in India have some hearing loss. Only about 15 lakh of them use a hearing aid. India has roughly 7,500 audiologists, the specialists trained to test hearing and tune the devices. About 2,800 of those audiologists work in the six biggest cities. Management says more than 60% of Indians have no audiologist nearby.
The company's answer is a device called OMNI, a tablet with headphones attached. It sits in a doctor's clinic rather than in a dedicated hearing centre. A specialist sitting far away runs the hearing test over the internet. The same specialist then tunes the hearing aid remotely. Earkart holds a patent for the system behind it. A patent is a legal right that stops others copying an invention for some years.
In October 2025 the company sold shares to the public for the first time. It listed on BSE SME, the part of the Bombay Stock Exchange for smaller companies. The issue raised ₹49 crore, of which ₹42 crore was fresh money for the company. The balance went to existing shareholders who sold some of their holdings.
A business named Forbes DGEMS listed Earkart in its 'Select 200' companies for 2025. That list names companies it considers to have global business potential. Earkart now sells in 22 states and union territories, from Mizoram to Kerala.
Business model
The main product is a tiny speaker that sits on or inside the ear. Earkart sells four brands of it.
Fame is a basic model, worn behind the ear, which makes all sounds louder. Radius is a digital model that a computer can tune to one person's hearing. EQFY is a receiver-in-canal model, with the speaker sitting inside the ear canal. A thin wire runs from the speaker to a small case behind the ear. Tiny sits deep in the ear, for people who prefer the device hidden.
Management explains why the digital models matter. A basic model makes traffic noise as loud as a friend's voice. A digital model sorts the sounds and lifts the voice above the horn. On an Indian road, that sorting has plenty of work to do.
Accessories follow the main product: batteries, wax guards, cleaning brushes and noise-protection earbuds. The company also sells therapy kits for children with disabilities, holding soft play material, massage balls and wooden blocks. Foldable walkers are on the list as well.
Sales reach buyers through four doors. Government buyers gave 61.32% of sales in FY26, mostly through GeM and ALIMCO. GeM is the government's own online shopping portal. ALIMCO is a government company that supplies aids to people with disabilities. Management describes government sales as growing at 'a very, very snail pace'.
Dealers and wholesalers buy in bulk and sell on to customers. The company says it works with about 1,400 dealer partners. The third door is the shop-in-shop clinic, where Earkart places an OMNI device inside an ENT doctor's clinic. ENT means ear, nose and throat. The doctor provides a quiet corner of six feet by six feet. Earkart pays for the device, about ₹3 lakh per clinic, management says. The clinic's assistant puts the headphones on the patient, and a distant specialist does the rest. The test fee is shared with the doctor, and the hearing aids are billed through the clinic. There are 82 such clinics today. The fourth door is services: hearing tests, franchise fees, consultancy and freight charges.
Quarterly results, balance sheet, cash flow, ratios, shareholding and the filings themselves are on the full page for EARKART LIMITED.
Companies in the same industry as EARKART LIMITED
Medical Equipment & Supplies